ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,172, issued on Feb. 3, was assigned to UNIVERSITAT AUTONOMA DE BARCELONA (UAB) (Bellaterra, Spain), FUNDACIO INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU (Barcelona, Spain) and CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P. (Madrid).

"Therapeutic nanoconjugates comprising Stefin a and uses thereof" was invented by Antonio Villaverde Corrales (Bellaterra, Spain), Esther Vazquez Gomez (Bellaterra, Spain), Ugutz Unzueta Elorza (Barcelona, Spain), Ramon Mangues Bafalluy (Barcelona, Spain), Maria Virtudes Cespedes Navarro (Barcelona, Spain), Isolda Casanova Rigat (Madrid) and Hector Lopez Laguna (Bellaterra, Spain).

According to the abstract* released by the U...